We herein analyze the transition of the NLR, MLR, PLR or CRP during the treatment with TNF-α inhibitors, IFX, ADA and CZP in patients with psoriasis and tried to determine which of the parameters can act as biomarkers reflecting the treatment response. The gene discussed is TNF; the disease is psoriasis.